Strategic Partnership with TPG to Drive Global Expansion
BVI Medical has raised $1 billion in capital through a strategic partnership with asset management firm TPG, enabling full debt refinancing and additional equity backing to accelerate product development and expand global reach in ophthalmology.
The funding boost comes as BVI intensifies efforts to meet rising demand for monofocal intraocular lenses (IOLs), including recent launches of its Serenity and Serenity Toric IOLs, and expanded European manufacturing capacity.
“This investment marks a pivotal moment as we redefine eye surgery and empower surgeons worldwide,” said President and CEO Shervin Korangy.
TPG emphasized its commitment to supporting BVI’s continued growth and innovation in ophthalmic care.
Follow MEDWIRE.AI for the latest in ophthalmic technology advancements.
